The Government and Companies Are Both Preparing for the (As Yet Unannounced) Pharma Tariffs
Shares:
Yesterday was all about Eliquis. First up were the patient listening sessions I keep prattling on about. And while there was some sense that the parade of speakers didn’t shed
I’m paying the price for yesterday’s decision to go all-in on the Minnesota 340B report. There’s a lot to get through. Pitter patter. Tomorrow’s Curve will be a game-time decision,
It’s a big day for PDABs. Buckle up. *** The biggest news is probably Amgen’s suit against the state of Colorado that makes the case that the prescription drug affordability